ENANTA PHARMACEUTICALS INC (ENTA) — insider trading
Health Care · NASDAQ
ENANTA PHARMACEUTICALS INC (ENTA) has 24 reported SEC Form 4 insider transactions in our data (latest 2026-03-11).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-03-11 | CARTER BRUCE L A | Director | Grant / award / vesting (derivative) | 20,000 | $0.00 | $0 | Form 4 |
| 2026-03-11 | FOLETTA MARK G | Director | Grant / award / vesting (derivative) | 20,000 | $0.00 | $0 | Form 4 |
| 2026-03-11 | Hata Yujiro S | Director | Grant / award / vesting (derivative) | 20,000 | $0.00 | $0 | Form 4 |
| 2026-03-11 | Peterson Kristine | Director | Grant / award / vesting (derivative) | 20,000 | $0.00 | $0 | Form 4 |
| 2026-03-11 | Russell Lesley | Director | Grant / award / vesting (derivative) | 20,000 | $0.00 | $0 | Form 4 |
| 2026-03-11 | Vance Terry | Director | Grant / award / vesting (derivative) | 20,000 | $0.00 | $0 | Form 4 |
| 2026-02-12 | Luly Jay R. | Director, Officer (President and CEO) | Shares withheld for taxes / exercise cost | 6,155 | $14.25 | $87.7K | Form 4 |
| 2026-02-12 | Luly Jay R. | Director, Officer (President and CEO) | Grant / award / vesting | 15,200 | $0.00 | $0 | Form 4 |
| 2026-02-12 | Luly Jay R. | Director, Officer (President and CEO) | Grant / award / vesting | 4,800 | $0.00 | $0 | Form 4 |
| 2026-02-12 | Or Yat Sun | Officer (Chief Scientific Officer) | Shares withheld for taxes / exercise cost | 3,413 | $14.25 | $48.6K | Form 4 |
| 2026-02-12 | Or Yat Sun | Officer (Chief Scientific Officer) | Grant / award / vesting | 5,225 | $0.00 | $0 | Form 4 |
| 2026-02-12 | Or Yat Sun | Officer (Chief Scientific Officer) | Grant / award / vesting | 1,650 | $0.00 | $0 | Form 4 |
| 2026-02-12 | Rottinghaus Scott T. | Officer (Chief Medical Officer) | Shares withheld for taxes / exercise cost | 3,413 | $14.25 | $48.6K | Form 4 |
| 2026-02-12 | Rottinghaus Scott T. | Officer (Chief Medical Officer) | Grant / award / vesting | 5,225 | $0.00 | $0 | Form 4 |
| 2026-02-12 | Rottinghaus Scott T. | Officer (Chief Medical Officer) | Grant / award / vesting | 1,650 | $0.00 | $0 | Form 4 |
| 2026-02-12 | Kieffer Tara Lynn | Officer (Chief Product Strategy Officer) | Shares withheld for taxes / exercise cost | 3,257 | $14.25 | $46.4K | Form 4 |
| 2026-02-12 | Kieffer Tara Lynn | Officer (Chief Product Strategy Officer) | Grant / award / vesting | 4,987 | $0.00 | $0 | Form 4 |
| 2026-02-12 | Kieffer Tara Lynn | Officer (Chief Product Strategy Officer) | Grant / award / vesting | 1,575 | $0.00 | $0 | Form 4 |
| 2026-02-12 | Luu Brendan | Officer (Chief Business Officer) | Shares withheld for taxes / exercise cost | 3,257 | $14.25 | $46.4K | Form 4 |
| 2026-02-12 | Luu Brendan | Officer (Chief Business Officer) | Grant / award / vesting | 4,987 | $0.00 | $0 | Form 4 |
| 2026-02-12 | Luu Brendan | Officer (Chief Business Officer) | Grant / award / vesting | 1,575 | $0.00 | $0 | Form 4 |
| 2026-02-12 | Kowalsky Matthew Paul | Officer (Chief Legal Officer) | Shares withheld for taxes / exercise cost | 1,902 | $14.25 | $27.1K | Form 4 |
| 2026-02-12 | Kowalsky Matthew Paul | Officer (Chief Legal Officer) | Grant / award / vesting | 4,175 | $0.00 | $0 | Form 4 |
| 2026-02-12 | Kowalsky Matthew Paul | Officer (Chief Legal Officer) | Grant / award / vesting | 1,318 | $0.00 | $0 | Form 4 |
Ask the chat about ENTA's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: ENANTA PHARMACEUTICALS INC (ENTA).
Last updated 2026-03-11 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.